KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Venrock Healthcare Capital Partners Iii, L.P. bought $236K of KalVista Pharmaceuticals, Inc.
10% owner
Bought$235,500
$9.42Price
25,000Shares
What KALV did for a copier
- $1,000 copied at Mon, Apr 14 open, $11.72
- $973
- S&P 500, same days
- +8.0%
Measured over 30 trading days, to the May 28 close.
Venrock Healthcare Capital Partners Iii, L.P.'s record
13 other buys with 3 months of prices since 2020: on average −5.9% against the S&P 500, and 4 of 13 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Apr 9. Filed Fri, Apr 11, 5:22 PM ET, after the close. Returns use the Apr 14 open and the May 28 close. Not investment advice.